Information About This Study:
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms in Patients with Celiac Disease on a Gluten Free Diet.
Study Number:
CeD-LA-3001
Indication:
Celiac Disease
Enrolling Now!
Please call Allegiance Research Specialists to see if you qualify: 414-727-8131.